LTBP1 promotes fibrillin incorporation into the extracellular matrix
暂无分享,去创建一个
R. Mecham | M. Paulsson | B. Callewaert | S. Mostert | B. Brachvogel | Veronika S. Georgieva | R. Wagener | G. Sengle | A. Schiavinato | M. Koch | B. Kobbe | F. Metzen | Matthias Przyklenk
[1] F. Alkuraya,et al. Bi-allelic premature truncating variants in LTBP1 cause cutis laxa syndrome. , 2021, American journal of human genetics.
[2] Jenq-Wen Huang,et al. LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure , 2021, Cell Death & Disease.
[3] J. Stetefeld,et al. Homogenous overexpression of the extracellular matrix protein Netrin-1 in a hollow fiber bioreactor , 2021, Applied Microbiology and Biotechnology.
[4] Z. Urban,et al. LTBP4 in Health and Disease , 2021, Genes.
[5] F. Alkuraya,et al. Bi-allelic premature truncating variants in LTBP1 cause cutis laxa syndrome. , 2021, American journal of human genetics.
[6] M. Paulsson,et al. Collagen type VI is the antigen recognized by the ER‐TR7 antibody , 2021, European journal of immunology.
[7] L. Duca,et al. Elastic fibers: formation, function, and fate during aging and disease , 2021, The FEBS journal.
[8] Daniel R. Martin,et al. Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development , 2021, bioRxiv.
[9] L. Soslowsky,et al. Collagen XII mediated cellular and extracellular mechanisms regulate establishment of tendon structure and function. , 2020, Matrix biology : journal of the International Society for Matrix Biology.
[10] R. Mecham,et al. Latent-transforming growth factor beta-binding protein-2 (LTBP-2) is required for longevity but not for development of zonular fibers. , 2020, Matrix biology : journal of the International Society for Matrix Biology.
[11] H. Yanagisawa,et al. Recent updates on the molecular network of elastic fiber formation. , 2019, Essays in biochemistry.
[12] Michael P. Lockhart-Cairns,et al. The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly , 2019, Matrix biology : journal of the International Society for Matrix Biology.
[13] J. Thomson,et al. Fibrillin microfibrils and elastic fibre proteins: Functional interactions and extracellular regulation of growth factors , 2019, Seminars in cell & developmental biology.
[14] R. Boot-Handford,et al. ADAMTS10-mediated tissue disruption in Weill–Marchesani syndrome , 2018, Human molecular genetics.
[15] Takako Sasaki,et al. Fibulin-4 deposition requires EMILIN-1 in the extracellular matrix of osteoblasts , 2017, Scientific Reports.
[16] T. Iwasaka,et al. Latent TGF-β binding protein 2 and 4 have essential overlapping functions in microfibril development , 2017, Scientific Reports.
[17] D. Keene,et al. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. , 2016, Gene.
[18] F. Ramirez,et al. Fibrillin microfibrils in bone physiology. , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[19] M. Brown,et al. Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia , 2016, Journal of Medical Genetics.
[20] L. Sakai,et al. The fibrillin microfibril scaffold: A niche for growth factors and mechanosensation? , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[21] R. Marschalek,et al. Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines. , 2015, Biotechnology journal.
[22] D. Rifkin,et al. Abrogation of both short and long forms of latent transforming growth factor-β binding protein-1 causes defective cardiovascular development and is perinatally lethal. , 2015, Matrix biology : journal of the International Society for Matrix Biology.
[23] K. Kameyama,et al. Latent TGF-β binding protein-2 is essential for the development of ciliary zonule microfibrils. , 2014, Human molecular genetics.
[24] M. Sideek,et al. LTBP-2 competes with tropoelastin for binding to fibulin-5 and heparin, and is a negative modulator of elastinogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[25] B. Kholodenko,et al. Evaluating Strategies to Normalise Biological Replicates of Western Blot Data , 2014, PloS one.
[26] R. Mecham,et al. Nonselective assembly of fibrillin 1 and fibrillin 2 in the rodent ocular zonule and in cultured cells: implications for Marfan syndrome. , 2013, Investigative ophthalmology & visual science.
[27] David A. Scott,et al. Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.
[28] P. Handford,et al. Structure of the Fibrillin-1 N-Terminal Domains Suggests that Heparan Sulfate Regulates the Early Stages of Microfibril Assembly , 2013, Structure.
[29] H. von Melchner,et al. Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5 , 2013, Proceedings of the National Academy of Sciences.
[30] D. Rifkin,et al. Specificity of latent TGF‐β binding protein (LTBP) incorporation into matrix: Role of fibrillins and fibronectin , 2012, Journal of cellular physiology.
[31] Seyed Hassan Paylakhi,et al. LTBP2 mutations cause Weill–Marchesani and Weill–Marchesani‐like syndrome and affect disruptions in the extracellular matrix , 2012, Human mutation.
[32] P. Handford,et al. TB domain proteins: evolutionary insights into the multifaceted roles of fibrillins and LTBPs. , 2011, The Biochemical journal.
[33] D. Rifkin,et al. Long form of latent TGF‐β binding protein 1 (Ltbp1L) regulates cardiac valve development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.
[34] G. Karsenty,et al. Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation , 2010, The Journal of cell biology.
[35] A. Ruys,et al. Rapid cell culture and pre-clinical screening of a transforming growth factor-β (TGF-β) inhibitor for orthopaedics , 2010, BMC musculoskeletal disorders.
[36] M. Abramowicz,et al. LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma , 2010, European Journal of Human Genetics.
[37] J. Keski‐Oja,et al. Matrix association of latent TGF‐beta binding protein‐2 (LTBP‐2) is dependent on fibrillin‐1 , 2009, Journal of cellular physiology.
[38] Y. Lau,et al. Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan‐like phenotypes , 2009, American journal of medical genetics. Part A.
[39] D. Mackey,et al. Null mutations in LTBP2 cause primary congenital glaucoma. , 2009, American journal of human genetics.
[40] A. Noor,et al. Oligodontia is caused by mutation in LTBP3, the gene encoding latent TGF-beta binding protein 3. , 2009, American journal of human genetics.
[41] M. McKee,et al. Fibrillin assembly requires fibronectin. , 2008, Molecular biology of the cell.
[42] R. Mecham,et al. Essential role for fibrillin‐2 in zebrafish notochord and vascular morphogenesis , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.
[43] A. Murphy,et al. Long form of latent TGF-β binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling , 2007 .
[44] M. Farach-Carson,et al. Potential Role for Heparan Sulfate Proteoglycans in Regulation of Transforming Growth Factor-β (TGF-β) by Modulating Assembly of Latent TGF-β-binding Protein-1* , 2007, Journal of Biological Chemistry.
[45] R. Fodde,et al. Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan‐related phenotypes , 2006, American journal of medical genetics. Part A.
[46] D. Rifkin,et al. Fibronectin is required for integrin o:vβ6‐mediated activation of latent TGF‐β complexes containing LTBP‐1 , 2005 .
[47] M. Humphries,et al. Fibronectin Regulates Latent Transforming Growth Factor-β (TGFβ) by Controlling Matrix Assembly of Latent TGFβ-binding Protein-1* , 2005, Journal of Biological Chemistry.
[48] R. Mecham,et al. Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment. , 2003, The Biochemical journal.
[49] A. Gressner,et al. The murine latent transforming growth factor-beta binding protein (Ltbp-1) is alternatively spliced, and maps to a region syntenic to human chromosome 2p21-22. , 2003, Gene.
[50] D. Matthys,et al. GENETIC FIBRILLINOPATHIES : NEW INSIGHTS IN MOLECULAR DIAGNOSIS AND CLINICAL MANAGEMENT , 2003, Acta clinica Belgica.
[51] D. Rifkin,et al. Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein* , 2003, The Journal of Biological Chemistry.
[52] Kamin J. Johnson,et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. , 2001, Nature Medicine.
[53] J. Rosenbloom,et al. Interaction of Tropoelastin with the Amino-terminal Domains of Fibrillin-1 and Fibrillin-2 Suggests a Role for the Fibrillins in Elastic Fiber Assembly* , 2000, The Journal of Biological Chemistry.
[54] L. Bonewald,et al. Role of the Latent Transforming Growth Factor β–Binding Protein 1 in Fibrillin‐Containing Microfibrils in Bone Cells In Vitro and In Vivo , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] J. Keski‐Oja,et al. Independent Promoters Regulate the Expression of Two Amino Terminally Distinct Forms of Latent Transforming Growth Factor-β Binding Protein-1 (LTBP-1) in a Cell Type-specific Manner* , 1999, The Journal of Biological Chemistry.
[56] K. Miyazono,et al. Efficient Association of an Amino-terminally Extended Form of Human Latent Transforming Growth Factor- Binding Protein with the Extracellular Matrix (*) , 1995, The Journal of Biological Chemistry.
[57] K. Miyazono,et al. Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. , 1988, The Journal of biological chemistry.
[58] A. Bosio,et al. Disruption of the latent transforming growth factor-β binding protein-1 gene causes alteration in facial structure and influences TGF-β bioavailability , 2008 .